WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor
Oncology September 07,2024
Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor
Oncology September 07,2024
Long-term conditions could delay lung cancer diagnosis, new study finds

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher
Oncology September 07,2024
Long-term conditions could delay lung cancer diagnosis, new study finds

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher
Oncology September 07,2024
Screening for skin cancer: Who is at risk?

Screening for skin cancer: Who is at risk?

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainThere are three major kinds of skin cancer—squamous cell carcinoma, basal cell carcinoma and melanoma. Melanoma is the most dangerous. The
Dermatology September 07,2024
Screening for skin cancer: Who is at risk?

Screening for skin cancer: Who is at risk?

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainThere are three major kinds of skin cancer—squamous cell carcinoma, basal cell carcinoma and melanoma. Melanoma is the most dangerous. The
Dermatology September 07,2024
Editorial: AI is a transformative tool in precision oncology

Editorial: AI is a transformative tool in precision oncology

by Impact Journals LLCOverview of AI model development for use in oncology patients. Credit: McGale et al.A new editorial was published inOncotarget, titled "Artificial intelligence: A tran
Technology & AI September 07,2024
Editorial: AI is a transformative tool in precision oncology

Editorial: AI is a transformative tool in precision oncology

by Impact Journals LLCOverview of AI model development for use in oncology patients. Credit: McGale et al.A new editorial was published inOncotarget, titled "Artificial intelligence: A tran
Technology & AI September 07,2024
An ancient signaling pathway and 20 years of research offer hope for rare cancer

An ancient signaling pathway and 20 years of research offer hope for rare cancer

byPeter MacCallum Cancer CentreCredit:EMBO Reports(2024). DOI: 10.1038/s44319-024-00217-3Researchers at Peter Mac are using their knowledge of an ancient signaling pathway to find ne
Oncology September 07,2024
An ancient signaling pathway and 20 years of research offer hope for rare cancer

An ancient signaling pathway and 20 years of research offer hope for rare cancer

byPeter MacCallum Cancer CentreCredit:EMBO Reports(2024). DOI: 10.1038/s44319-024-00217-3Researchers at Peter Mac are using their knowledge of an ancient signaling pathway to find ne
Oncology September 07,2024
Scientists find way to starve breast cancer cells

Scientists find way to starve breast cancer cells

by Jennifer Michalowski,Cold Spring Harbor LaboratoryWhen fast-growing breast cancer cells run out of glutamine, they turn to an alternative supply line. PHGDH (above, in green) is a key enzyme
Oncology September 07,2024
Scientists find way to starve breast cancer cells

Scientists find way to starve breast cancer cells

by Jennifer Michalowski,Cold Spring Harbor LaboratoryWhen fast-growing breast cancer cells run out of glutamine, they turn to an alternative supply line. PHGDH (above, in green) is a key enzyme
Oncology September 07,2024
Editorial: Genotype matters—tailored screening for germline CHEK2 variants

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var
Oncology September 07,2024
Editorial: Genotype matters—tailored screening for germline CHEK2 variants

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var
Oncology September 07,2024
Scientists discover how the body's killer cells attack cancer

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working
Oncology September 07,2024
Scientists discover how the body's killer cells attack cancer

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working
Oncology September 07,2024
Graph filtration learning reveals new dimensions in hepatocellular carcinoma imaging

Graph filtration learning reveals new dimensions in hepatocellular carcinoma imaging

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial was published inOncotarget, titled "Beyond pixels: Graph filtration learning unveils new dimensions in hepatocellular
Oncology September 07,2024
Graph filtration learning reveals new dimensions in hepatocellular carcinoma imaging

Graph filtration learning reveals new dimensions in hepatocellular carcinoma imaging

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial was published inOncotarget, titled "Beyond pixels: Graph filtration learning unveils new dimensions in hepatocellular
Oncology September 07,2024
New study supports annual breast cancer screening for women over 40

New study supports annual breast cancer screening for women over 40

by Asher Jones and Cynthia Patton,University of Pittsburgh Schools of the Health SciencesCredit: Pixabay/CC0 Public DomainWomen diagnosed with breast cancer who had regular screening mammograms
Oncology September 07,2024
New study supports annual breast cancer screening for women over 40

New study supports annual breast cancer screening for women over 40

by Asher Jones and Cynthia Patton,University of Pittsburgh Schools of the Health SciencesCredit: Pixabay/CC0 Public DomainWomen diagnosed with breast cancer who had regular screening mammograms
Oncology September 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com